Orion Bioscience is an early stage Nebraska-based biotechnology company focused on developing a platform technology that targets a wide range of autoimmune diseases. Their Soluble Antigen Array platform and ORNx formulation technology enable the development of novel therapies for severe antibody-mediated diseases. By restoring immune tolerance, their therapeutic modalities aim to ameliorate the devastating effects of autoimmune diseases, providing patients with new treatment options.